DNA hypomethylation and ovarian cancer biology
- PMID: 15231656
- DOI: 10.1158/0008-5472.CAN-04-0238
DNA hypomethylation and ovarian cancer biology
Abstract
Hypomethylation of some portions of the genome and hypermethylation of others are very frequent in human cancer. The hypomethylation often involves satellite 2 (Sat2) DNA in the juxtacentromeric (centromere-adjacent) region of chromosome 1. In this study, we analyzed methylation in centromeric and juxtacentromeric satellite DNA in 115 ovarian cancers, 26 non-neoplastic ovarian specimens, and various normal somatic tissue standards. We found that hypomethylation of both types of satellite DNA in ovarian samples increased significantly from non-neoplastic toward cancer tissue. Furthermore, strong hypomethylation was significantly more prevalent in tumors of advanced stage or high grade. Importantly, extensive hypomethylation of Sat2 DNA in chromosome 1 was a highly significant marker of poor prognosis (relative risk for relapse, 4.1, and death, 9.4) and more informative than tumor grade or stage. Also, comparing methylation of satellite DNA and 15 5' gene regions, which are often hypermethylated in cancer or implicated in ovarian carcinogenesis, we generally found no positive or negative association between methylation changes in satellite DNA and in the gene regions. However, hypermethylation at two loci, CDH13 (at 16q24) and RNR1 (at 13p12), was correlated strongly with lower levels of Sat2 hypomethylation. The CDH13/Sat2 epigenetic correlation was seen also in breast cancers. We conclude that satellite DNA hypomethylation is an important issue in ovarian carcinogenesis as demonstrated by: (a) an increase from non-neoplastic tissue toward ovarian cancer; (b) an increase within the ovarian cancer group toward advanced grade and stage; and (c) the finding that strong hypomethylation was an independent marker of poor prognosis.
Similar articles
-
DNA hypomethylation is prevalent even in low-grade breast cancers.Cancer Biol Ther. 2004 Dec;3(12):1225-31. doi: 10.4161/cbt.3.12.1222. Epub 2004 Dec 9. Cancer Biol Ther. 2004. PMID: 15539937 Review.
-
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.Oncogene. 2006 Apr 27;25(18):2636-45. doi: 10.1038/sj.onc.1209145. Oncogene. 2006. PMID: 16532039 Free PMC article.
-
Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.Mutat Res. 1999 Jan 25;423(1-2):91-101. doi: 10.1016/s0027-5107(98)00229-2. Mutat Res. 1999. PMID: 10029684
-
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer.Gynecol Oncol. 2011 Apr;121(1):24-31. doi: 10.1016/j.ygyno.2010.12.332. Epub 2011 Jan 20. Gynecol Oncol. 2011. PMID: 21251700 Free PMC article.
-
DNA methylation in cancer: too much, but also too little.Oncogene. 2002 Aug 12;21(35):5400-13. doi: 10.1038/sj.onc.1205651. Oncogene. 2002. PMID: 12154403 Review.
Cited by
-
Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.Oncol Lett. 2016 Jul;12(1):157-166. doi: 10.3892/ol.2016.4608. Epub 2016 May 18. Oncol Lett. 2016. PMID: 27347118 Free PMC article.
-
Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer.Front Oncol. 2014 Feb 4;4:12. doi: 10.3389/fonc.2014.00012. eCollection 2014. Front Oncol. 2014. PMID: 24551595 Free PMC article. Review.
-
FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer.Int J Mol Sci. 2014 Oct 8;15(10):17963-73. doi: 10.3390/ijms151017963. Int J Mol Sci. 2014. PMID: 25299694 Free PMC article.
-
The integrative epigenomic-transcriptomic landscape of ER positive breast cancer.Clin Epigenetics. 2015 Dec 9;7:126. doi: 10.1186/s13148-015-0159-0. eCollection 2015. Clin Epigenetics. 2015. PMID: 26664652 Free PMC article.
-
DNA Methyltransferase Activity Assays: Advances and Challenges.Theranostics. 2016 Jan 6;6(3):369-91. doi: 10.7150/thno.13438. eCollection 2016. Theranostics. 2016. PMID: 26909112 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous